Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

FAMOTIDINE INJECTIO

Awarded
SPE2DP26F7013Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded contract SPE2DP26F7013 to DMS Pharmaceutical Group Inc on July 2, 2026, as a delivery order under the primary contract SPE2DX25D9900. This firm-fixed-price award is for the procurement of Famotidine Injection, identified by NSN 6505016467199 and part number NDC63323-0738-20. The total contract value is 150.14 dollars for a quantity of 2.000 PG at a unit price of 75.07 dollars, with no permitted quantity variance. The items are to be delivered to the 99th MDG SGSM at Nellis Air Force Base, Nevada, by July 2, 2026. Shipping must be conducted via traceable means, and the use of parcel post is strictly prohibited. The contract is established as FOB Destination, meaning the contractor is responsible for all costs and risks until the shipment reaches its destination, where both inspection and acceptance will occur. Packaging must be clearly marked with the manufacturer CAGE code 57KZ6, the NSN, the part number, and the contract and procurement request numbers to ensure proper military logistics tracking.

General Info

DLA awarded DMS Pharmaceutical Group $150.14 for Famotidine Injection delivered to Nellis AFB.

Contract Value

$150.14

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DP26F7013 - Famotidine Injection Award

PDF, High priority: read this firstaward
High

SPE2DP26F7013.pdf

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F7013 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $150.14 Award Date: 07-02-2026 Delivery order under: SPE2DX25D9900 Line items: - FAMOTIDINE INJECTIO (NSN/Part 6505016467199, PR 7017383463)

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
Atropine Auto-Injector
Solicitation # SPE2DP-27-R-ATRO
DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.
DLA Troop Support

POSTED

about 7 hours ago

DEADLINE

in about 1 month
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS